Pro-ficiency has been named a winner of the ‘TBJ Fastest 50’ award by the Triangle Business Journal

DURHAM, N.C., November 9th, 2023 – The Triangle Business Journal has named Pro-ficiency a winner of the ‘TBJ Fastest 50 award’, placing Pro-ficiency 31st out of 50 recipients. This award recognizes the 50 fastest-growing private companies in the Triangle region of North Carolina.

Pro-ficiency is a leading provider of simulation-based training solutions in life sciences. By using a proprietary simulation approach combined with deep subject matter expertise, learners achieve understanding and life science leaders gain insight into learner competency and potential risk areas.

Pro-ficiency’s inclusion on the Fastest 50 list is a testament to the company’s rapid growth and its innovative approach to simulation-based training. The company’s solutions enable learners to achieve deep understanding and competency in complex life science concepts, while also providing life science leaders with critical insights into their teams’ performance.

“We are honored to be named among the Triangle Business Journal’s Fastest 50,” said Michael Raymer, CEO of Pro-ficiency. “This recognition is a testament to our team’s dedication to developing innovative solutions that help our customers achieve their goals.”

Pro-ficiency recently acquired Compass Group Partners, a prominent family of companies specializing in medical communications for the life sciences industry. This acquisition has expanded Pro-ficiency’s capabilities into the medical affairs and commercial space, opening new avenues for innovation across all service offerings of the combined company. See the press release to learn more: https://pro-ficiency.newswire.com/news/pro-ficiency-acquires-compass-group-partners-and-affiliated-assets-22059994

With its continued growth and innovation, Pro-ficiency is well-positioned to continue leading the way in simulation-based training for the life sciences industry.

About Pro-ficiency

Pro-ficiency is a leading provider of simulation-based training and compliance solutions for clinical trials. The company provides a comprehensive suite of services, anchored by their innovation in customized, virtual training simulations, training and compliance monitoring tools, and real-time data & predictive analytics. Combined with protocol optimization, process visualization tools and professional production video capabilities, Pro-ficiency achieves improved intelligence for learners and critical risk intelligence for leaders. Learn more at pro-ficiency.com.

Contact:

Collin Brooks, Marketing Manager

collin.brooks@pro-ficiency.com, +1 919.909.0420

Brad Stefanovic, Clinical Operations and Innovation Leader, Joins Pro-ficiency

DURHAM, N.C., October 19, 2023 – Pro-ficiency, a leading provider of simulation-based training solutions in life sciences, has appointed Brad Stefanovic to lead the organization’s clinical trial innovation efforts. As a former Clinical Operations leader, Stefanovic brings a unique perspective on challenges facing clinical study operations, including how Pro-ficiency can address those issues. In addition, as a former advocate of Pro-ficiency solutions, he can convey the power of simulation-based training solutions from his real-world experience.

“It’s unique to find a team member that has not only talked about the need for change in our profession, but has been active in driving change for years,” said Jenna Rouse, Chief Clinical Markets Officer. “His deep understanding of the challenges facing clinical study operations, combined with his passion for innovation, make him the ideal person to lead our efforts in helping clients to proactively manage risk and improve the efficiency and effectiveness of their clinical trials.”

Brad Stefanovic brings over 17 years of experience in the clinical research industry to Pro-ficiency. He has held senior leadership positions at several leading pharmaceutical companies and contract research organizations (CROs), where he has overseen all aspects of clinical trial design, execution, and management. Stefanovic is also a recognized expert in the use of simulation and modeling to improve the efficiency and effectiveness of clinical trials.

“We are delighted to welcome Brad to the Pro-ficiency team,” said Michael Raymer, CEO of Pro-ficiency. “Brad’s deep expertise spanning from clinical research through commercialization make him the ideal person to lead our efforts in bringing simulation-based training solutions to clients. We are confident that Brad will play a key role in driving client quality through his ability to bridge the gap between theory and practice.”

Stefanovic holds a PhD in Physiology from the University of the Sunshine Coast in Australia and was Alumni of the year in 2022.

About Pro-ficiency

Pro-ficiency is a leading provider of simulation-based training and compliance solutions for clinical trials. The company provides a comprehensive suite of services, anchored by their innovation in customized, virtual training simulations, training and compliance monitoring tools, and real-time data & predictive analytics. Combined with protocol optimization, process visualization tools and professional production video capabilities, Pro-ficiency achieves improved intelligence for learners and critical risk intelligence for leaders. Learn more at pro-ficiency.com.

Contact:

Collin Brooks, Marketing Manager

collin.brooks@pro-ficiency.com, +1 919.909.0420

Pro-ficiency Acquires Compass Group Partners and Affiliated Assets

DURHAM, N.C., June 13th, 2023 – Pro-ficiency, the leading provider of simulation-based training solutions for clinical trials, has announced its acquisition of Compass Group Partners, a prominent family of companies specializing in medical communications for the life sciences industry. This strategic acquisition will expand simulation-based technologies into the medical affairs and commercial space, opening new avenues for innovation across all service offerings of the combined company.  

By integrating Compass Group Partner’s expertise with Pro-ficiency’s advanced simulation technology, the combined company is now able to offer immersive simulation solutions to address the complexities of the medical affairs and commercial markets. Through interactive simulations, professionals in the field will gain practical experience to optimize diagnosis, treatment selection, and patient monitoring.  

“The acquisition aligns with Pro-ficiency’s vision to revolutionize drug development by bridging the gap between theory and practice,” said Pro-ficiency’s CEO, Michael Raymer. “There is a proven demand for simulation in the markets that Compass Group Partners serves. Combining Pro-ficiency’s unique simulation methodology with their medical communication expertise will create revenue expansion opportunities for the new entity, and ultimately contribute to the delivery of safe and effective drugs to patients worldwide”.

“I founded Caravel Group, and then our parent company Compass Group Partners, to serve as a true strategic and innovation partner to our clients in the life sciences industry,” said Murry Alper, Pro-ficiency’s new Chief Commercial Markets Officer. “This partnership will allow us to bring a new dimension of simulation and analytics to medical affairs and commercial clients. Together, we can revolutionize how professionals acquire critical information while broadening our reach and achieving a measurable impact”.

“This union has created a unique organization in life sciences with an extensive global network, deep expertise across the drug development and commercialization continuum. The solutions suite is grounded in elegant technology poised to set a new standard in this space. The growth and innovation potential are very exciting”, said Renie Dornbusch, Pro-ficiency’s new Chief Commercial Operations Officer.

Compass Group Partners is led by Murry Alper and Renie Dornbusch and serves as the parent company for the Caravel Group Medical Communications, Eclipse Event Management, Zuma Medical Communications and the Panorama KOL Management Platform. The full Compass Group Partners team, assets and client roster, will remain intact to ensure client continuity, but will merge with the Pro-ficiency service suite to bolster capabilities and expertise for all clients across the combined organization.

The Compass Group Partners companies and collection of services will be consolidated under the Caravel Group name.

This is the second acquisition for Pro-ficiency since their funding by QHP Capital (management company for NovaQuest Private Equity) in 2021. 

About Compass Group Partners

Compass Group Partners was established in 2006 as a full service marketing and communications agency in life sciences. Acquiring Eclipse Meeting Productions in 2013 and merging with Zuma Clinical Communications in 2014, the combined family of companies delivers on active partnerships with many of the top 10 global pharmaceutical companies. They are known for creating impactful, value-based and customer-centric solutions that support drug development and commercialization from development to commercialization.

About Pro-ficiency

Pro-ficiency is a leading provider of simulation-based training and compliance solutions for clinical trials. The company provides a comprehensive suite of services, anchored by their innovation in customized, virtual training simulations, training and compliance monitoring tools, and real-time data & predictive analytics. Combined with protocol optimization, process visualization tools and professional production video capabilities, Pro-ficiency achieves improved intelligence for learners and critical risk intelligence for leaders. Learn more at proficiency3.wpengine.com.

Contact:

Collin Brooks, Marketing Manager

collin.brooks@pro-ficiency.com, +1 919.909.0420

Pro-ficiency Launches Pf Library to Expand Study Training Service Suite

Pro-ficiency is excited to announce the launch of Pf Library, an innovative online document hosting center that provides convenient access to relevant study resources within the Pro-ficiency platform.  Pf Library seamlessly integrates with the Pro-ficiency training portal, providing a comprehensive platform for training and supporting sites, study teams and Sponsors.

Pf Library offers study team managed document hosting functionality for convenient 24/7 access to relevant study resources and documents. The library offers unlimited file storage capabilities for virtually any type of file, providing clients with flexibility to upload any study-relevant resources including: study manuals, guides, templates, standard operating procedures (SOPs), press releases, webinars, videos, and more.

Each client-managed portal offers optional automatic notifications to learners when new or updated resources are available. Additionally, Pf library has the capability to track utilization and viewer metrics.

“Giving sites a single source for study-related guidance was a natural evolution for Pro-ficiency” said Michael Raymer, CEO of Pro-ficiency. “But we wanted to improve on solutions already available on the market. What we have released with Pf Library is a platform that is easy to access, easy to manage, and easy to navigate, all without complex user fees. When we can remove barriers for sites to access study critical information, we all win.”

For more information please visit our website: https://www.pro-ficiency.com/performance-management-platform

About Pro-ficiency

Pro-ficiency is a leading provider of simulation-based training and compliance solutions for clinical trials. The company provides a comprehensive suite of services, anchored by their innovation in customized, virtual training simulations, training and compliance monitoring tools, and real-time data & predictive analytics. Combined with protocol optimization, process visualization tools and professional production video capabilities, Pro-ficiency achieves improved intelligence for learners and critical risk intelligence for leaders. Learn more at pro-ficiency.com

Pro-ficiency Releases Simulation-Based Good Clinical Practice (GCP) Training Program

DURHAM, N.C., March 23rd, 2022 – Pro-ficiency has launched a new Good Clinical Practice (GCP) Simulation training program. This program is immediately available to the public after the publication of this press release for free.

The goal of this interactive simulation-based program is to set a new standard for GCP training compliance and competency development, while also facilitating a more effective, more enjoyable, and less time-consuming learning experience.

The Pro-ficiency GCP Simulation program immerses learners in a cutting-edge adaptive learning environment, building critical thinking and decision-making skills needed to apply GCP principles in the real world. Participants play the roles of study coordinator, investigator, sub-investigator, research nurse, and study monitor/CRA in a variety of simulated scenarios, practicing the application of GCP concepts in a safe environment so they can apply the tenets of good clinical practice in their real world setting.

This ICH E6 GCP Investigator Site Training meets the Minimum Criteria for ICH GCP Investigator Site Personnel Training identified by TransCelerate BioPharma as necessary to enable mutual recognition of GCP training among trial sponsors.

For more information, please visit: http://pro-ficiency.com/gcp-sign-ups-public-enrollment

About Pro-ficiency

Pro-ficiency is a leading provider of simulation-based training and compliance solutions for clinical trials. The company provides a comprehensive suite of services, including turn-key customized, virtual training simulations, training and compliance monitoring tools, and real-time data & predictive analytics. Learn more at https://www.pro-ficiency.com.

Contact:

Collin Brooks, Marketing Manager

collin.brooks@pro-ficiency.com, +1 919.909.0420

Pro-ficiency has been selected as a ‘Top Ten Tech Startup to Watch in 2022’ by the NC Tech Awards

The NC Tech Awards has named Pro-ficiency as one of the Top Ten Tech Startups to Watch of 2022. This award signifies the innovative progress Pro-ficiency has made, and the potential for further success and expansion in 2023 and beyond.

Pro-ficiency is a next-generation learning engine specializing in life sciences. By using a proprietary simulation approach combined with deep subject matter expertise, learners achieve understanding and life science leaders gain insight into learner competency and potential risk areas.

Michael Raymer, Pro-ficiency’s CEO, said “One of the biggest indicators of future success is recognition of progress, with this NC Tech Award confirming what we’ve known for years, that Pro-ficiency’s proprietary simulation-based approach is the future of training for clinical trials.”

With the clinical arena shifting towards a hybrid-virtualized approach, remote training platforms that can ensure consistent protocol understanding across geographies and languages are essential for driving study compliance and enrollment. Pro-ficiency’s simulation-based training is positioned to change the future of clinical trials by providing engaging training that generates robust performance metrics. This evolved approach drives proactive risk management for sponsors and CROs, improves enrollment, and reduces protocol deviations for studies in any phase, and any therapeutic area.

 

About Pro-ficiency

Pro-ficiency is a leading provider of simulation-based training and compliance solutions for clinical trials. The company provides a comprehensive suite of services, including turn-key customized, virtual training simulations, training and compliance monitoring tools, and real-time data & predictive analytics. Learn more at proficiency3.wpengine.com.

Pro-ficiency Launches New Solution: Pro-Active Protocol

Pro-ficiency announced today the launch of Pro-Active Protocol, a unique and proprietary protocol optimization methodology that applies simulation to visually represent the study operational flow. 

This expansion complements the organization’s current scope of training services by providing studies with an essential resource to vet the protocol with study teams, regulatory agencies and patients prior to protocol finalization. The solution can be rapidly produced and updated as it is intended to shed light on protocol inconsistencies and gaps so study teams can adjust and revise. 

With the end goal of a better-designed study, Pro-Active Protocol integrates seamlessly with Pro-ficiency’s existing simulation-based protocol modules or can serve as a stand-alone resource, to increase study and site team understanding of the study requirements upon study start-up.

Beth Harper, Pro-ficiency’s Chief Learning Officer, said “One of the biggest challenges in clinical trials is developing a well designed protocol that sites can operationalize. This tool has the power to help sponsors identify possible inconsistencies and challenges before they turn into deviations, it improves the site’s ability to evaluate feasibility, and facilitates a more patient-centric drug development process. This could be one of the easiest, quickest and most effective ways to positively impact a clinical study from the start”.

Pro-ficiency’s Pro-Active Protocol solution is available immediately for studies in any phase and in any therapeutic area. To learn more about our new solution visit: http://proficiency1.wpenginepowered.com/pro-active-protocol

 

About Pro-ficiency

Pro-ficiency is a leading provider of simulation-based training and compliance solutions for clinical trials. The company provides a comprehensive suite of services, including turn-key customized, virtual training simulations, training and compliance monitoring tools, and real-time data & predictive analytics. Learn more at proficiency3.wpengine.com.

 

Contact:

Collin Brooks, Marketing Manager

collin.brooks@pro-ficiency.com, +1 919.909.0420

Pro-ficiency Acquires Fugitive Labs

Pro-ficiency announces the acquisition of all life sciences intellectual property and the associated team of Fugitive Labs, a full-service nationwide product development firm. This acquisition significantly increases Pro-ficiency’s platform and product development capabilities, which will serve to increase the organization’s competitive advantage in clinical trials performance management. The expanded development team will foster Pro-ficiency’s ability to deliver on a robust development pipeline for years to come.

“The Fugitive team is an incredible addition for us,” said Pro-ficiency CEO, Michael Raymer. “It’s rare to find a product team that understands clinical trials and also develops beautiful, simple, and highly functional user experiences. To have the Fugitive team fully dedicated to innovation within Pro-ficiency is going to keep us lightyears ahead of others in our space.”

The Fugitive Labs team is led by Erik Guffrey, Fugitive Labs CEO, now Pro-ficiency’s Chief Technology Officer. Mr. Guffrey brings a team of product developers with him to focus on building and enhancing the Pro-ficiency suite of products and services. One notable member of the team is Grant Fowler, co-founder of Fugitive, joining Pro-ficiency as Senior Vice President of Engineering. Having over 9 years of experience working alongside Erik at Fugitive, his insight will prove invaluable in facilitating a smooth integration of new features into Pro-ficiency’s platform.

“What Pro-ficiency is doing to evolve performance in clinical trials is truly unique and exciting,” said Erik Guffrey, Pro-ficiency’s new Chief Technology Officer. “This team (at Pro-ficiency) is relentless about thinking differently to address problems for study teams and learners at the site. Having the resources, creative support and collaborative approach with a leadership team like this is a dream situation for any developer. We can make magic happen.”

Included in the acquisition of Fugitive Labs is a collection of ready-made platforms built specifically for clinical trial use and tested with major CROs and sponsors.

The acquisition marks the first for Pro-ficiency since their funding by NovaQuest Private Equity in 2021. Rollout plans for the acquired platforms and newly developed services will be announced in future press releases.

 

About Fugitive Labs

The Fugitive Labs core team includes a focused group of designers, engineers, and strategists skilled at combining rapid prototyping toward MVP (Minimum Viable Product) with the long-term product vision needed to achieve scale. Their areas of expertise include web and mobile development, API development, user experience, interface design and interaction design.

 

About Pro-ficiency

Pro-ficiency is a leading provider of simulation-based training and compliance solutions for clinical trials. The Company provides a comprehensive suite of services, including turn-key customized, virtual training simulations, training and compliance monitoring tools, and real-time data & predictive analytics. Learn more at proficiency3.wpengine.com.

 

Contact:

Collin Brooks, Marketing Manager

collin.brooks@pro-ficiency.com, +1 919.909.0420

Jeanne Hecht Joins Pro-ficiency Board of Directors

Durham, North Carolina, June 23rd, 2022 – Pro-ficiency completes its strategic board expansion initiative with the appointment of Jeanne Hecht to the organization’s Board of Directors.

“Considering Jeanne’s reputation as a visionary in clinical trials, her appointment is an incredible win for Pro-ficiency,” said Pro-ficiency President and Founder, Dave Hadden. “Her impact on both small and large organizations is profound. Having her guidance is going to be integral to ensuring that we’re continuing to innovate, meet emerging and existing challenges in the profession, and that we’re setting new standards for how companies make study-related decisions”.

“I have a passion for helping companies with high-impact solutions realize their potential and Pro-ficiency provides a unique opportunity to revolutionize how companies are using human performance to take proactive action in their studies,” said Hecht. “The opportunities are endless so I’m excited to provide any guidance I can to ensure strategic, effective growth so more organizations can evolve how they think about learning within their organizations”.

Jeanne Hecht currently serves as CEO of JTH Consulting, LLC and serves as Non-Executive Director on life science and healthcare IT Boards of Directors. Her leadership in clinical trials spans over 25 years from CEO of Ora, COO of Median Technologies and senior roles at IQVIA, VP of Marketing and Sales for Decision Biomarkers, Inc. and Regulatory Affairs Officer for the UNC Oncology Protocol Office.

Hecht’s expertise in adult learning runs deep as she currently serves as Advisory Board Member for the University of North Carolina Chapel Hill Kenan-Flagler’s Business School Center for the Business of Health. She is also a founder member of the Wake Forest University’s master’s in clinical research program and remains an active industry advisor to the school.

 

About Pro-ficiency

Pro-ficiency is a leading provider of simulation-based training and compliance solutions for clinical trials. The Company provides a comprehensive suite of services, including turn-key customized, virtual training simulations, training and compliance monitoring tools, and real-time data & predictive analytics. Learn more at proficiency3.wpengine.com.

 

Contact:

Collin Brooks, Marketing Manager

collin.brooks@pro-ficiency.com, +1 919.909.0420

Robin Newman Joins Pro-ficiency Board of Directors

Durham, North Carolina, June 9th, 2022 – Pro-ficiency continues to expand its thought leadership representation on their Board of Directors with the addition of Robin Newman, RN, MSN, EdD, CPNP. 

“We hit the jackpot when Robin agreed to join our Board. The breadth of her leadership across the clinical trials landscape is astounding, but her doctorate in organizational learning and development means she really understands what we do, how it’s done, and how it impacts clinical trials” said Pro-ficiency President and Founder, Dave Hadden. “Her insights on how to apply our approach for medical devices is going to be a game changer for us too.”

“When you look at the root cause of many of the pervasive issues facing clinical trials, they stem from human understanding” said Dr. Newman. “I’ve been in leadership in clinical trials for decades and Pro-ficiency’s approach is one of the few solutions I’ve seen that I truly believe can move that needle in a meaningful direction, for sponsors, for sites and for patients. Joining the Board of Directors was an easy decision”.

For more than 25 years, Dr. Newman has dedicated her career to building better futures for patients through developing healthcare solutions in the medical device and biopharmaceutical industries. As a leader in business and philanthropy, Dr. Newman has her research roots firmly planted in the healthcare industry, beginning as a Clinical Research Coordinator and Pediatric Nurse Practitioner to her current role as Global VP for Clinical Affairs at Beckman Coulter Diagnostics and Life Sciences.  

She holds both Bachelor and Master degrees in Nursing from the University of Texas at Austin and Arlington, where she was honored as a Distinguished Alumni, and a doctorate in Human & Organizational Learning and Development from The George Washington University. 

Prior to joining Beckman Coulter, Dr. Newman served as the WW VP for Clinical Affairs  and WW Vice President, Clinical, Preclinical and Medical Strategic R&D at Johnson & Johnson, the Director of the Office of Compliance at the Center for Devices and Radiological Health, US Food & Drug Administration, VP Quality, Regulatory, and Clinical Affairs at Siemens Healthcare Diagnostics, and Founder and CSO of MedTrials, a clinical research and regulatory consulting firm headquartered in Dallas, Texas. Dr. Newman has also served as member and Chair of the Board of Trustees for the Association of Clinical Research Professionals.

 

About Pro-ficiency

Pro-ficiency is a leading provider of simulation-based training and compliance solutions for clinical trials. The Company provides a comprehensive suite of services, including turn-key customized, virtual training simulations, training and compliance monitoring tools, and real-time data & predictive analytics. Learn more at proficiency3.wpengine.com.

 

Contact:

Collin Brooks, Marketing Manager

collin.brooks@pro-ficiency.com, +1 919.909.0420